Chris Brightling

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 16:19, October 10, 2020 by Notjusttired (talk | contribs) (start)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Professor Chris Brightling or Christopher Brightling is a British doctor and researcher specialising in respiratory conditions in Leicester, UK.[1][2][3]

Long COVID

Chris Brightling is chief investigator for the PHOSP-COVID study, a post-hospitalisation COVID-19 study which aims to investigate long-term outcomes of patients with severe COVID-19, and may run for up to 25 years.[4]

Talks and interviews

Notable studies

See also

Learn more

References

  1. ↑ https://www2.le.ac.uk/departments/iii/people/brightling
  2. ↑ https://le.ac.uk/research/coronavirus/professor-chris-brightling
  3. ↑ https://www.nhs.uk/profiles/consultant/4021092
  4. ↑ https://www.leicesterbrc.nihr.ac.uk/themes/respiratory/research/phosp-covid/
Retrieved from "https://me-pedia.org/w/index.php?title=Chris_Brightling&oldid=85146"